Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services in China and internationally. The company offers fluorine-co...
Shanghai Composite Nears Positive Territory, Pharmaceutical Stocks Surge, Computing Hardware Stocks Continue to Adjust, HSI Fluctuates Higher, New Consumption Concept Stocks Rebound, POP MART Rises 2%
Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTec
CRO concept stocks fluctuated and strengthened, with Fushine and Menovo both hitting the daily limit, Kingchem rising more than 10%, and Biocytogen, BHC, and ChemPartner following suit
Kingchem: The net profit for the third quarter was 31.6687 million yuan, a year-on-year increase of 339.92%
Kingchem released its performance for the first half of the year, with a net profit attributable to the parent company of 71.7606 million yuan, an increase of 123.61%
Kingchem: The company's existing products and business do not involve the field of PEEK materials